Maersk lands Novo Nordisk cold-chain deal

  • January 4, 2021
  • Steve Rogerson

Danish pharmaceutical company Novo Nordisk has hired AP Moller-Maersk to handle its cold-chain logistics for the next three years.

The agreement, which starts in April, covers transportation including ocean services and inland logistics.

“We are proud to be chosen as one of Novo Nordisk´s main logistic companies,” said Vincent Clerc, executive vice president at Maersk. “Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions. This achievement showcases the rapid transformation of AP Moller-Maersk as a modern end-to-end logistics company with fully controlled assets.”

One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen Maersk’s Eco Delivery to reduce the carbon footprint in transportation. The initiative uses sustainable biofuel to power selected Maersk vessels and helps Novo Nordisk make progress towards its sustainability goals.

“Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business,” said Rune Sylow, corporate vice president at Novo Nordisk. “We consider AP Moller-Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.”

AP Moller-Maersk is an integrated container logistics company working to connect and simplify its customers’ supply chains. The company operates in 130 countries and employs roughly 80,000 people.